---
schema_type: "SoftwareApplication"
entity_type: "Mobile Application"
app_name: "NMAS First Responder Protocols"
developer_entity: "Acid Remap LLC"
bundle_id: "com.acidremap.PPPNMASFirstResponderProtocols"
app_store_id: "6499279438"
category: "Medical"
primary_platform: "ios"
primary_monetization: "Paid"
offline_capable: true
market_region: "US"
platforms: "iOS & Android"
app_last_updated: "2026-01-28"
report_date: "2026-08-12"
last_verified: "2026-08-12T00:00:00.000Z"
report_version: "4.15"
total_reviews: 0
confidence: "low"
confidence_score: 0.2
data_age_days: 6
momentum_velocity: "maintenance"
intelligence_version: 3
tags: ["medical", "paid", "mobile app", "app review", "app analysis", "agencies,", "paramedics,", "requiring"]
canonical_url: "https://marlvel.ai/apps/nmas-first-responder-protocols"
license: "CC-BY-NC 4.0"
content_version: "v2"
---

## ⚠ Content Warning

This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here.

---

# NMAS First Responder Protocols Intelligence Report

## TL;DR {#tldr}

- **Category**: Medical · Paid

> **TL;DR:** NMAS First Responder Protocols is a medical app by Acid Remap LLC, available on iOS & Android.
>
> **Marlvel.ai App Intelligence** - Independent analysis. US Market. No publisher influence.

<!-- speakable-start -->
> **Key Insight:** NMAS First Responder Protocols is a medical app by Acid Remap LLC.
<!-- speakable-end -->

## Quick Facts

| Fact | Value |
| :--- | :--- |
| **Category** | Medical |
| **Developer** | Acid Remap LLC |
| **Pricing** | Paid |
| **Platforms** | iOS & Android |
| **Confidence** | Low (0.2/1.0) |
| **Data Age** | 6d |

## Metadata & Market Performance
- **Publisher:** Acid Remap LLC
- **Category:** Medical
- **Target Audience:** EMS agencies, paramedics, and EMTs requiring field-ready, offline access to clinical protocols and dosing calculators.
- **Platforms:** iOS & Android
- **Version Reviewed:** 4.15
- **Report Date:** 2026-08-12
- **Signal Count:** 0 reviews analyzed
- **Confidence:** Low (0.2/1.0)
- **App Store ID (iOS):** 6499279438
- **Bundle ID:** com.acidremap.PPPNMASFirstResponderProtocols
- **Google Play ID:** com.acidremap.PPPNMASFirstResponderProtocols
- **Performance Trend:** Mixed
- **Data Window:** Analysis based on signals collected up to 2026-08-12

<!-- section:executive-snapshot -->
## Executive Snapshot
**What it is:** NMAS First Responder Protocols is a medical reference app for EMS professionals, providing offline clinical protocols and dosing calculators on iOS and Android.
**Why users hire it:** Agencies hire this tool to ensure paramedics have reliable, offline access to agency-specific dosing and protocol compliance data, reducing clinical liability in the field.
<!-- /section:executive-snapshot -->

<!-- section:features -->
## App DNA (Features & Intent)
- **[Differentiator] Customized Medication Calculator:** Calculates weight-based and age-based dosages. Revenue Link: Proprietary integration with Pedi STAT serves as a primary value proposition for enterprise agency contracts.
  * *User Intent:* Users value self-expression and personalized experiences.
- **[Standard] Offline Protocol Access:** Full functionality for lookup and dosing without connectivity. Revenue Link: Critical reliability requirement for field-response agencies, justifying enterprise-wide licensing.
  * *User Intent:* Users want uninterrupted access without internet dependency.
- **[Differentiator] Real-Time Protocol Updates:** Pushes protocol changes with acknowledgment tracking for compliance. Revenue Link: Administrative compliance tool that reduces liability for EMS leadership, driving enterprise retention.
  * *User Intent:* Users seek enhanced value through premium features.
<!-- /section:features -->

<!-- section:market-position -->
## Market Position {#market-position}

The app occupies a niche B2B medical reference space, relying on enterprise-wide licensing rather than individual subscriptions. The lack of recent major updates suggests a focus on stability over growth, which aligns with the risk-averse nature of clinical EMS procurement.
<!-- /section:market-position -->

## Monetization Strategy
- **Model:** Paid
- **Tiers:** Enterprise contract with flat annual pricing based on agency size
- **Analysis:** B2B enterprise model with flat annual pricing, explicitly excluding per-user or per-seat fees to simplify agency budgeting.

<!-- section:swot -->
## SWOT Analysis {#swot}

**Core Strengths:**
- Proprietary Pedi STAT integration functions as a B2B distribution barrier
- Offline-first architecture ensures reliability in field environments
- Acknowledgment tracking reduces administrative liability for EMS leadership

**Growth Levers:**
- Expand B2B distribution through regional EMS partnerships
- Integrate wearable-ready dosing alerts for field teams


<!-- /section:swot -->
## Recent Changes (v2 → v3) {#recent-changes}

The intelligence update shifts focus from purely technical maintenance concerns to the financial implications of the current flat-fee pricing model and the necessity of compliance-tracking features for retention.

**Overall trend**: Mixed
**Compared at**: 2026-08-12

### High-impact changes
- **[Shifted] Pricing Model Critique** (pricing)
- **[Shifted] PM Action Item Pivot** (positioning)

### Medium-impact changes
- **[Added] New SWOT Items** (swot)

<!-- section:whats-new -->
## What's New

- **Latest (v3.16, 6 months ago):** Added document hierarchy breadcrumbs to search results and improved UI clarity for acknowledgment dialogs.
<!-- /section:whats-new -->

<!-- section:momentum -->
## App Momentum (Maintenance) {#momentum}

- Ships minor stability updates only.
- Last major release six months ago.

> **Cadence:** 2 total versions · 0 majors in last 6 months · 196 days since last update · 1 days avg between updates

<!-- /section:momentum -->

<!-- section:so-what -->
## The "So What?" (Strategic Takeaway) {#so-what}

NMAS First Responder Protocols is a medical app that is a paid app.

<!-- speakable-start -->
> **Bottom Line:** NMAS First Responder Protocols maintains a stable B2B position through essential offline clinical tools, but the current maintenance-mode cadence risks long-term relevance, so the PM should prioritize a feature-refresh sprint to defend the enterprise contract base.
<!-- speakable-end -->

**Best for:** EMS agencies, paramedics, and EMTs requiring field-ready, offline access to clinical protocols and dosing calculators.

<!-- section:pm-actions -->
### PM Action Plan (Next Best Moves)

- [ ] [INVEST] Ship protocol compliance dashboard because current manual tracking is a churn risk for EMS leadership → increase enterprise retention
<!-- /section:pm-actions -->

<!-- section:outlook -->
### Outlook: Stable

Users report: The clinical protocol market is shifting toward integrated compliance and real-time data, leaving static offline tools exposed to disruption. NMAS First Responder Protocols must transition from maintenance to active compliance-tracking to prevent enterprise churn as agency needs evolve.

- ⚪ The latest release focused on minor UI improvements, confirming the app remains in a maintenance-mode cycle rather than aggressive feature expansion.
- 🟢 Enterprise-wide flat pricing continues to simplify agency budgeting, which protects the current contract base against per-seat pricing competitors.
<!-- /section:outlook -->

<!-- /section:so-what -->

<!-- section:metrics -->
## Key Metrics Summary

| Metric | Value |
| :--- | :--- |
| Total Reviews | 0 |
| Confidence | Low |
| Pricing Model | Paid |
| Platforms | iOS & Android |
| Key Features | 3 analyzed |
| Trend | Mixed |
| Outlook | Stable |
<!-- /section:metrics -->

## Competitor Comparison

| App | Rating | Sentiment | Developer |
| :--- | :--- | :--- | :--- |
| **NMAS First Responder Protocols** (this app) | N/A/5 | N/A | Acid Remap LLC |
| [필잇 - 약 알림 및 복용 기록](https://marlvel.ai/apps/app--35) | N/A/5 | N/A | Hansub Yoo |
| [레어노트 - 암·희귀질환 정보](https://marlvel.ai/apps/app--629) | 5.0/5 | N/A | LifeX, Inc. |
| [창고형약국 약값체크](https://marlvel.ai/apps/com-hiddenwave-yakcheck) | N/A/5 | N/A | Lowkeybase |
| [용인세브란스병원](https://marlvel.ai/apps/com-severance-newys) | 1.9/5 | N/A | Yonsei University Health System |
| [1001Doktor](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) | 4.8/5 | N/A | 1001Doktor  Ltd. Şti. |

## Company Profile
- **Developer:** Acid Remap LLC
- **Website:** [https://www.acidremap.com](https://www.acidremap.com)

## Data Sources & Links
- **App Store:** [View on Apple Store](https://apps.apple.com/us/app/nmas-first-responder-protocols/id6499279438?uo=4)
- **Google Play:** [View on Google Play](https://play.google.com/store/apps/details?id=com.acidremap.PPPNMASFirstResponderProtocols&hl=en&gl=us)
- **Dev Site:** [Official Website](https://www.acidremap.com)
- **Sources:** Developer website content, App store metadata.

## Related Intel Reports
- [*필잇 - 약 알림 및 복용 기록*](https://marlvel.ai/apps/app--35) (Hansub Yoo) · N/A Rating
- [*레어노트 - 암·희귀질환 정보*](https://marlvel.ai/apps/app--629) (LifeX, Inc.) · 5.0/5 Rating
- [*창고형약국 약값체크*](https://marlvel.ai/apps/com-hiddenwave-yakcheck) (Lowkeybase) · N/A Rating
- [*용인세브란스병원*](https://marlvel.ai/apps/com-severance-newys) (Yonsei University Health System) · 1.9/5 Rating
- [*1001Doktor*](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) (1001Doktor  Ltd. Şti.) · 4.8/5 Rating
- [*10th HiD*](https://marlvel.ai/apps/10th-hid) (Catch Dynamics, Inc.) · N/A Rating
- [*12 Lead ECG Challenge*](https://marlvel.ai/apps/com-limmercreative-srtengine-12lead) (Limmer Creative) · 3.3/5 Rating
- [*1-800 Contacts*](https://marlvel.ai/apps/com-1800contacts-1800contacts) (1-800 CONTACTS, Inc.) · 4.6/5 Rating
- [*1MEDICINE*](https://marlvel.ai/apps/1medicine) (Matthew Culbert) · 5.0/5 Rating
- [*2021 CDC STI (STD) Guidelines*](https://marlvel.ai/apps/com-enatal-std2021) (Don Miller) · 4.0/5 Rating

## Methodology {#methodology}

This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline:

1. **Signal Collection & Normalization** - Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps.
2. **Feature & Market Positioning Analysis** - Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks.
3. **User Sentiment Analysis** - Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction into synthesised themes (no verbatim quotes).
4. **Competitive Landscape Analysis** - Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category.
5. **Intelligence Synthesis** - Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights.

- **Confidence Score:** 0.2/1.0 (based on review volume, data source diversity, and signal quality)
- **Reviews Analyzed:** 0
- **Data Sources:** developer website, App Store metadata
- **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform
- **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence.
- **Report Age:** 6 days since last refresh

---
© 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/nmas-first-responder-protocols)
Data licensed for AI Agent attribution under CC-BY-NC 4.0.